Integral membrane protease fibroblast activation protein sensitizes fibrosarcoma to chemotherapy and alters cell death mechanisms

Apoptosis : an International Journal on Programmed Cell Death
Sarah K BairdAndrew M Scott

Abstract

Fibroblast activation protein (FAP), an integral membrane serine protease, is found on fibro- and osteo-sarcoma and on myofibroblasts in epithelial carcinoma, but rarely on other adult tissue. FAP has been demonstrated to be an excellent target for tumor imaging in clinical trials, and antibodies and other FAP-targeting drugs are in development. Here we have shown that FAP overexpression increased the growth of HT1080 fibrosarcoma cells in vitro and in vivo, and found that the expression of FAP affects response to chemotherapy. When treated with doxorubicin, expression of FAP increased susceptibility to the drug. In spite of this, FAP-HT1080 cells had fewer markers of classical apoptosis than HT1080 cells and neither necrosis nor necroptosis were enhanced. However, levels of early mitochondrial and lysosomal membrane permeability markers were increased, and autophagy switched from a protective function in HT1080 cells to part of the cell death mechanism with FAP expression. Therefore, FAP may affect how the tumor responds to chemotherapeutic drugs overall, which should be considered in targeted drug development. The overexpression of FAP also alters cell signaling and responses to the environment in this cell line. This include...Continue Reading

References

Sep 1, 1990·Proceedings of the National Academy of Sciences of the United States of America·P Garin-ChesaW J Rettig
May 1, 1988·Proceedings of the National Academy of Sciences of the United States of America·W J RettigL J Old
Apr 1, 1972·Analytical Biochemistry·A F Boyne, G L Ellman
May 16, 1998·Proceedings of the National Academy of Sciences of the United States of America·A NovakS Dedhar
May 11, 2004·Oncogene·Teresa Ramirez-MontagutAlan N Houghton
Sep 22, 2005·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Xin Maggie WangMark D Gorrell
Jun 24, 2006·The Journal of Clinical Investigation·Markus LoefflerRalph A Reisfeld
Nov 16, 2006·Arthritis Research & Therapy·Stefan BauerChristoph Renner
Jul 17, 2008·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Elinborg OstermannGuenther R Adolf
Oct 11, 2008·Cell Death and Differentiation·G KroemerUNKNOWN Nomenclature Committee on Cell Death 2009
May 7, 2009·Molecular Cancer Therapeutics·Aaron M LeBeauSamuel R Denmeade
Jun 9, 2009·Clinical Oncology : a Journal of the Royal College of Radiologists·R M EagerJ Nemunaitis
Aug 1, 2009·BMC Cancer·Robert M EagerJohn Nemunaitis
Feb 3, 2011·Journal of Drug Targeting·Sichao HuangShaohui Cai
Aug 14, 2013·Journal of Translational Medicine·Petra C SchuberthUlf Petrausch
Feb 13, 2014·Oncology Letters·Lixiang DingWen G Jiang

❮ Previous
Next ❯

Citations

Aug 19, 2020·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Darpan N PandyaThaddeus J Wadas

❮ Previous
Next ❯

Related Concepts

Related Feeds

Carcinosarcoma

Carcinosarcoma is a malignant neoplasm that contains elements of carcinoma and sarcoma so extensively intermixed as to indicate neoplasia of epithelial and mesenchymal tissue. Discover the latest research on carcinosarcoma here.

Autophagy & Model Organisms

Autophagy is a cellular process that allows degradation by the lysosome of cytoplasmic components such as proteins or organelles. Here is the latest research on autophagy & model organisms

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis